PathoSense developed a complete sample-collection-to-diagnostic-interpretation platform for infectious diseases in veterinary medicine. Using nanopore sequencing, PathoSense can detect all viruses and bacteria without prior selection in all animal species. This will bring the veterinary insights and advice to a higher level. Available via partner laboratories in Europe.
Pathosense offers comprehensive analyses of bacterial communities to get insights in the microbiome with a particular but non-exclusive focus on animal health. We stand out in our human touch during the guidance from study design to data interpretation. Furthermore, we continuously improve our services thanks to innovations such as shotgun metagenomics and direct metabolite (eg. SCFA) measuring.
PathoSense specializes in whole-genome sequencing of micro-organisms, offering complete genomes and detailed genomic characterization of bacteria, yeasts, viruses, phages and plasmids. Our fast and cost-effective service encompasses nucleic acid extraction, long-read sequencing, expert bioinformatics analysis, and thorough reporting.
"PathoSense's journey all started with the launch of its unique PathoSense diagnostic assay for identification of all virus and bacteria in diseased animals, without prior selection. The PathoSense Dx assay is becoming increasingly available via partnerships with frontline veterinary diagnostic laboratories. Moreover, PathoSense offers a broad range of sequencing services designed to meet the specific needs of each customer. Such sequencing services include microbiome analyses and whole genome sequencing of pathogens such as viruses, bacteria and yeast. Although not limited, our expertise exploits itself best in the animal health industry. Indeed, our goal goes beyond just delivering a report, we aim to actively support our clients in effectively resolving their challenges. Being a certified service provider by Oxford Nanopore Technologies, PathoSense ensures that its services meet the highest quality standards."